These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 20383727)

  • 1. Combined thrombophilic factors increase the risk of recurrent thrombotic events in Behcet's disease.
    Yaşar NŞ; Salgür F; Cansu DÜ; Kaşifoğlu T; Korkmaz C
    Clin Rheumatol; 2010 Dec; 29(12):1367-72. PubMed ID: 20383727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A study on thrombophilic factors in Italian Behcet's patients.
    Caramaschi P; Poli G; Bonora A; Volpe A; Tinazzi I; Pieropan S; Bambara LM; Biasi D
    Joint Bone Spine; 2010 Jul; 77(4):330-4. PubMed ID: 20452800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular involvement in Behçet's disease: relation with thrombophilic factors, coagulation activation, and thrombomodulin.
    Espinosa G; Font J; Tàssies D; Vidaller A; Deulofeu R; López-Soto A; Cervera R; Ordinas A; Ingelmo M; Reverter JC
    Am J Med; 2002 Jan; 112(1):37-43. PubMed ID: 11812405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Could be serum uric acid a risk factor for thrombosis and/or uveitis in Behcet's disease?
    Atıl A; Deniz A
    Vascular; 2018 Aug; 26(4):378-386. PubMed ID: 29360007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do hemorheological alterations play any role in the development of thrombotic events in Behçet's disease?
    Vayá A; Ricart J; Todolí J; Micó L; Contreras T; Aznar J
    Clin Hemorheol Microcirc; 2004; 30(3-4):411-4. PubMed ID: 15258375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombophilic risk factors and homocysteine levels in Behçet's disease in eastern Spain and their association with thrombotic events.
    Ricart JM; Vayá A; Todolí J; Calvo J; Villa P; Estellés A; España F; Santaolaria M; Corella D; Aznar J
    Thromb Haemost; 2006 Apr; 95(4):618-24. PubMed ID: 16601831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperhomocysteinaemia in Behçet's disease.
    Aksu K; Turgan N; Oksel F; Keser G; Ozmen D; Kitapçioğlu G; Gümüşdiş G; Bayindir O; Doğanavşargil E
    Rheumatology (Oxford); 2001 Jun; 40(6):687-90. PubMed ID: 11426028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombophilic factors are not the leading cause of thrombosis in Behçet's disease.
    Leiba M; Seligsohn U; Sidi Y; Harats D; Sela BA; Griffin JH; Livneh A; Rosenberg N; Gelernter I; Gur H; Ehrenfeld M
    Ann Rheum Dis; 2004 Nov; 63(11):1445-9. PubMed ID: 15479893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fatal pulmonary artery thrombosis in a patient with Behçet's disease, activated protein C resistance and hyperhomocystinemia.
    Misgav M; Goldberg Y; Zeltser D; Eldor A; Berliner AS
    Blood Coagul Fibrinolysis; 2000 Jul; 11(5):421-3. PubMed ID: 10937802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiannexin V autoantibody in thrombophilic Behçet's disease.
    Aslan H; Pay S; Gok F; Baykal Y; Yilmaz MI; Sengul A; Aydin HI
    Rheumatol Int; 2004 Mar; 24(2):77-9. PubMed ID: 14658002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythrocyte aggregation in Behçet's disease determined with the Sefam and Myrenne aggregometer. Lack of association with thrombosis and uveitis.
    Ricart JM; Vayá A; Todolí J; Santaolaria ML; Calvo J; Aznar J
    Clin Hemorheol Microcirc; 2005; 33(4):389-96. PubMed ID: 16317248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Mean Platelet Volume in Patients With Behcet's Disease as an Indicator of Vascular Thrombosis.
    Ataş H; Canpolat F; Eskioglu F
    Arch Iran Med; 2018 Jun; 21(6):234-239. PubMed ID: 29940741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coagulation parameters and plasma total homocysteine levels in Behcet's disease.
    Lee YJ; Kang SW; Yang JI; Choi YM; Sheen D; Lee EB; Choi SW; Song YW
    Thromb Res; 2002 Apr; 106(1):19-24. PubMed ID: 12165284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased mean platelet volume in Behçet's disease with thrombotic tendency.
    Acikgoz N; Karincaoglu Y; Ermis N; Yagmur J; Atas H; Kurtoglu E; Cansel M; Barutcu I; Pekdemir H; Ozdemir R
    Tohoku J Exp Med; 2010 Jun; 221(2):119-23. PubMed ID: 20484842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Why are male patients with Behçet's disease prone to thrombosis? A rotational thromboelastographic analysis.
    Kara Kivanc B; Gönüllü E; Akay OM; Ertürk A; Bal C; Cansu DÜ; Korkmaz C
    Clin Exp Rheumatol; 2018; 36(6 Suppl 115):63-67. PubMed ID: 29998845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A rare but serious manifestation of Behçet's disease: intracardiac thrombus in 22 patients.
    Emmungil H; Yaşar Bilge NŞ; Küçükşahin O; Kılıç L; Okutucu S; Gücenmez S; Kalyoncu U; Kaşifoğlu T; Turgay M; Aksu K
    Clin Exp Rheumatol; 2014; 32(4 Suppl 84):S87-92. PubMed ID: 25068833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased erythrocyte deformability in Behçet's disease.
    Usküdar O; Erdem A; Demiroğlu H; Dikmenoğlu N
    Clin Hemorheol Microcirc; 2005; 33(2):89-94. PubMed ID: 16151256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythrocyte deformability does not seem to be altered in Behçet's disease.
    Simó M; Ricart JM; Santaolaria M; Ortí G; Vayá A
    Clin Hemorheol Microcirc; 2007; 36(1):83-8. PubMed ID: 17211064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombin activatable fibrinolysis inhibitor in Behçet's disease.
    Donmez A; Aksu K; Celik HA; Keser G; Cagirgan S; Omay SB; Inal V; Aydin HH; Tombuloglu M; Doganavsargil E
    Thromb Res; 2005; 115(4):287-92. PubMed ID: 15668188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behçet's disease complicated with thrombosis: a report of 93 Chinese cases.
    Wu X; Li G; Huang X; Wang L; Liu W; Zhao Y; Zheng W
    Medicine (Baltimore); 2014 Dec; 93(28):e263. PubMed ID: 25526452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.